Multidrug-resistant tuberculous meningitis in an HIV-positive patient: A challenging disease

被引:5
作者
Meybeck, A. [1 ]
Calbet, J.
Ruimy, R.
Mashri, K.
Jachym, M.
Joly, V.
Yeni, P.
机构
[1] Hop Bichat Claude Bernard, Serv Malad Infect & Trop A, F-75877 Paris 18, France
[2] Hop Bichat Claude Bernard, Serv Bacteriol, F-75877 Paris, France
[3] Ctr Med Bligny, Sanat, Briis Sous Forges, France
关键词
ACTIVE ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; RIFAMPICIN RESISTANCE; INFECTION; ERA;
D O I
10.1089/apc.2006.0058
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We report two cases of disseminated multidrug-resistant tuberculosis with meningitis in HIV-positive patients, who were both recent emigrants from sub-Saharan Africa. Our two cases highlight new challenges in the care of HIV and tuberculosis coinfection including early diagnosis and treatment of multidrug-resistant tuberculosis that is spreading.
引用
收藏
页码:149 / 153
页数:5
相关论文
共 20 条
  • [1] [Anonymous], 1991, MMWR, V40, P585
  • [2] Treatment and prevention of multidrug-resistant tuberculosis
    Bastian, I
    Colebunders, R
    [J]. DRUGS, 1999, 58 (04) : 633 - 661
  • [3] TUBERCULOUS MENINGITIS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    BERENGUER, J
    MORENO, S
    LAGUNA, F
    VICENTE, T
    ADRADOS, M
    ORTEGA, A
    GONZALEZLAHOZ, J
    BOUZA, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (10) : 668 - 672
  • [4] Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin:: Case report
    Berning, SE
    Cherry, TA
    Iseman, MD
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (04) : 643 - 646
  • [5] Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis
    Chan, ED
    Laurel, V
    Strand, MJ
    Chan, JF
    Huynh, MLN
    Goble, M
    Iseman, MD
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (10) : 1103 - 1109
  • [6] Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
    Dean, GL
    Edwards, SG
    Ives, NJ
    Matthews, G
    Fox, EF
    Navaratne, L
    Fisher, M
    Taylor, GP
    Miller, R
    Taylor, CB
    de Ruiter, A
    Pozniak, AL
    [J]. AIDS, 2002, 16 (01) : 75 - 83
  • [7] Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy
    Dheda, K
    Lampe, FC
    Johnson, MA
    Lipman, MC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) : 1670 - 1676
  • [8] Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
    Di Perri, G
    Bonora, S
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (03) : 593 - 602
  • [9] The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis -: a molecular story
    Drobniewski, FA
    Wilson, SM
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1998, 47 (03) : 189 - 196
  • [10] Worldwide incidence of multidrug-resistant tuberculosis
    Dye, C
    Espinal, MA
    Watt, CJ
    Mbiaga, C
    Williams, BG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (08) : 1197 - 1202